The Addition of Hydromorphone to Local Anesthetics for the Repair of Inguinal Hernias in Elderly Patients

NCT ID: NCT06218160

Last Updated: 2024-01-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

63 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-01

Study Completion Date

2023-12-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare the clinical and postoperative analgesic effects of hydromorphone combined with ropivacaine and ropivacaine alone in quadrangular muscle block for open inguinal hernia in elderly patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Elderly patients selected for Lichtenstein hernia repair in our hospital who met the inclusion and exclusion criteria and obtained informed consent were included in this trial, and were randomly divided into experimental group by random number table method: 0.375% ropivacaine combined with hydromorphone block group, and control group: 0.375% ropivacaine block group alone.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inguinal Hernia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hydromorphone combined with ropivacaine

The posterior quadrat block was performed by adding 1mg hydromorphone to 0.375% ropivacaine in a total of 30ml.

Group Type EXPERIMENTAL

Hydromorphone combined with ropivacaine

Intervention Type DRUG

1mg hydromorphone was added to 0.375% ropivacaine for a total of 30ml to perform quadrat block

ropivacaine

A mixture of 0.375% ropivacaine for a total of 30ml was performed for posterior quadrate block.

Group Type ACTIVE_COMPARATOR

Ropivacaine

Intervention Type DRUG

A mixture of 0.375% ropivacaine for a total of 30ml was used for quadrate block

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hydromorphone combined with ropivacaine

1mg hydromorphone was added to 0.375% ropivacaine for a total of 30ml to perform quadrat block

Intervention Type DRUG

Ropivacaine

A mixture of 0.375% ropivacaine for a total of 30ml was used for quadrate block

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Quadratus lumbois block Quadratus lumbois block

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 60 and above.
* Admission to hospital for open inguinal hernia surgery is consistent with the -indications of this surgical modality, ASA grades 1 to 3.
* No recent use of sedatives, opioids, or other analgesics.
* Good compliance, signed informed consent.
* Complete clinical data.

Exclusion Criteria

* There are serious cardiovascular and cerebrovascular diseases.
* Abdominal infection.
* Coagulation dysfunction or receiving anticoagulation therapy.
* Local anesthesia drug allergy.
* Can not cooperate with the corresponding operation, suffering from mental illness.
* Previous surgical history of the corresponding position in the abdomen that may interfere with the surgical process of this study.
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Second Hospital of Jilin University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dan Tian

Role: STUDY_DIRECTOR

Second Hospital of Jilin University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Second Hospital of Jilin University

Changchun, Jilin, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022/148

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Phase 2/3 Study of TLC590 for Postsurgical Pain Management
NCT05161637 NOT_YET_RECRUITING PHASE2/PHASE3
Herniorrhaphy for Postoperative Pain
NCT05813847 RECRUITING PHASE3